Source: Eur Respir Monogr 2011; 54: 15-31
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Lazor. Alveolar haemorrhage syndromes. Eur Respir Monogr 2011; 54: 15-31

Member's Comments

Katarzyna Wyskida - 14.11.2016 12:08
Excellent chapter

Related content which might interest you: Granulomatosis with polyangiitis (Wegener&s) Source: Eur Respir Mon 2011; 54: 1-14 Year: 2011 Classification and new developments in the pathogenesis of vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=50 Year: 2005 Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69 Year: 2005 New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020 Year: 2020 c-ANCA-induced neutrophil-mediated lung injury: a model of acute Wegener's granulomatosis Source: Eur Respir J 2010; 36: 187-195 Year: 2010 Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 38: 1081-1088 Year: 2011 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Source: Eur Respir J 2016; 48: 1429-1441 Year: 2016 Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases Source: International Congress 2014 – ILDs 6 Year: 2014 Biologics for eosinophilic granulomatosis with polyangiitis Source: Short video statement 2020 Year: 2020 Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis Source: International Congress 2019 – Pulmonary vascular diseases? Year: 2019 Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Microscopic polyangiitis and granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 153-172 Year: 2019 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 188-209 Year: 2019 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2022; 95: 177-192 Year: 2022 Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) Source: Eur Respir J, 57 (5) 2004158; 10.1183/13993003.04158-2020 Year: 2021 ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015